Xi'an International Medical Investment Company Limited / Fundamentals
Income statement
- Net revenue
€536.39M - Cost of goods sold
€489.87M - Gross profit
€46.52M - SG&A expenses
€25.07M - R&D expenses
€848.77K - EBITDA
-€21.72M - D&A
€41.89K - EBIT
-€40.30M - Interest expenses
€19.05M - EBT
-€40.81M - Tax expenses
€2.14M - Net income
-€29.73M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€88.36M - Changes in working capital
€0.00 - Operating cash flow
€83.70M - Capex
€47.11M - Other investing cash flow
-€1.27M - Net investing cash flow
-€37.75M - Total cash dividends paid
-€19.35M - Issuance of common stock
€0.00 - Debt repayment
-€115.05M - Other financing cash flow
-€6.78M - Net financing cash flow
-€141.18M - Foreign exchange effects
€0.00 - Net change in cash
-€48.62M - Cash at end of period
€32.19M - Free cash flow
€130.80M
Balance sheet
- Cash and cash equivalents
€48.18M - Cash and short-term investments
€50.03M - Total receivables
€78.20M - Inventory
€7.37M - Other current assets
€8.01M - Total current assets
€143.62M - Property, plant & equipment
€887.47M - Goodwill
€0.00 - Intangible assets
€83.91M - Long-term investments
€0.00 - Other non-current assets
€87.13M - Total non-current assets
€1.07B - Total assets
€1.21B - Accounts payable
€210.55M - Short-term debt
€106.85M - Other current liabilities
€189.52M - Total current liabilities
€509.93M - Long-term debt
€311.35M - Deferred tax liabilities
€290.64K - Other non-current liabilities
€762.18K - Total non-current liabilities
€313.02M - Total liabilities
€822.94M - Common stock
€271.13M - Retained earnings
-€17.56M - Other equity
€0.00 - Total equity
€388.73M - Total liabilities and shareholders' equity
€1.21B
Company information
- Market capitalization
€1.38B - Employees
8.2K - Enterprise Value
€14.71B
Company ratios
- Gross margin
-
8.7% Much worse than peer group: 30.6% - EBITDA margin
-
-4.0% Worse than peer group: 11.1% - EBIT margin
-
-7.5% Worse than peer group: 4.4% - EBT margin
-
-7.6% Worse than peer group: 4.4% - Net margin
-
-5.5% Worse than peer group: 2.9% - ROE
-
-7.6% Worse than peer group: 9.2% - ROA
-
-2.5% Worse than peer group: 5.4% - Asset turnover
-
44.3% Worse than peer group: 60.6% - FCF margin
-
6.8% Even with peer group: 2.4% - FCF yield
2.7% - Efficiency ratio
104.0% - Net sales per employee
-
€65.63K - Net income per employee
-
-€3.64K